— Know what they know.
Not Investment Advice
Also trades as: 0LOV.L (LSE) · $vol 0M · 2VSA.F (FSX) · $vol 0M

VSTM NASDAQ

Verastem, Inc.
1W: -9.3% 1M: -29.6% 3M: -28.0% YTD: -40.9% 1Y: -46.8% 3Y: -15.3% 5Y: -87.9%
$4.24
-0.03 (-0.70%)
 
Weekly Expected Move ±10.5%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 27 · $293.9M mcap · 53M float · 3.96% daily turnover · Short 75% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$31M +209.1% ▲
5Y CAGR: -19.0%
Gross Profit
$26M +156.2% ▲
5Y CAGR: -14.1%
Operating Income
-$170M -48.0% ▼
Net Income
-$209M -60.3% ▼
EPS (Diluted)
$-3.02 +17.5% ▲
EBITDA
-$170M -35.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$2M$3M$0$10M$31M
YoY Growth-99.3%+328.4%-100.0%+0.0%+209.1%
Cost of Revenue$0$0$0$0$5M
Gross Profit$2M$3M$0$10M$26M
Gross Margin100.0%100.0%100.0%82.9%
R&D Expenses$39M$51M$61M$81M$115M
SG&A Expenses$24M$25M$31M$44M$81M
Operating Expenses$63M$76M$92M$125M$196M
Operating Income-$61M-$73M-$92M-$115M-$170M
Operating Margin-2991.2%-2809.6%-1149.6%-550.3%
Interest Expense$10M$2M$4M$5M$1M
Income Before Tax-$71M-$74M-$87M-$130M-$209M
Tax Expense$0$0$0$185K$0
Net Income-$71M-$74M-$87M-$131M-$209M
Net Margin-3468.1%-2843.3%-1306.4%-677.6%
EPS (Diluted)$-4.92$-4.57$-3.96$-3.66$-3.02
EBITDA-$61M-$72M-$83M-$126M-$170M
Shares Outstanding15M16M22M36M69M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms